Yext Inc
For the period ended Jan 31, 2025. Filed Mar 13, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 13, 2025
YEXT$7.67+1.2%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 8. Consolidated Statements of Cash Flows
(In thousands)
| Fiscal year ended January 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Operating activities: | |||
| Net loss | $(27,948) | $(2,630) | $(65,938) |
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||
| Depreciation and amortization expense | 18,531 | 15,805 | 17,583 |
| Bad debt expense | 1,665 | 888 | 182 |
| Stock-based compensation expense | 51,780 | 44,961 | 63,078 |
| Amortization of operating lease right-of-use assets | 8,729 | 8,804 | 8,799 |
| Adjustments to contingent consideration | 5,500 | — | — |
| Other, net | (2,597) | 540 | 1,195 |
| Changes in operating assets and liabilities, net of assets acquired and liabilities assumed in a business acquisition: | |||
| Accounts receivable | (1,122) | 518 | (10,056) |
| Prepaid expenses and other current assets | (397) | 755 | (2,303) |
| Costs to obtain revenue contracts | 10,048 | 8,818 | 8,034 |
| Other long term assets | 351 | 896 | 1,140 |
| Accounts payable, accrued expenses and other current liabilities | 17,037 | (10,176) | 2,714 |
| Unearned revenue | (20,464) | (11,252) | 3,538 |
| Operating lease liabilities | (11,095) | (11,687) | (10,986) |
| Other long term liabilities | 193 | (83) | 873 |
| Net cash provided by operating activities | 50,211 | 46,157 | 17,853 |
| Investing activities: | |||
| Capital expenditures | (2,085) | (2,728) | (6,193) |
| Cash paid in acquisition, net of cash acquired | (89,407) | — | — |
| Net cash used in investing activities | (91,492) | (2,728) | (6,193) |
| Financing activities: | |||
| Proceeds from exercise of stock options | 1,290 | 9,405 | 714 |
| Repurchase of common stock | (17,907) | (23,086) | (77,250) |
| Payments for taxes related to net share settlement of stock-based compensation awards | (10,826) | (13,015) | (5,129) |
| Payments of deferred financing costs | (853) | (452) | (509) |
| Deferred acquisition payments | (3,542) | — | — |
| Proceeds, net from employee stock purchase plan withholdings | 3,297 | 3,894 | 3,153 |
| Net cash used in financing activities | (28,541) | (23,254) | (79,021) |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | (1,708) | (205) | (3,635) |
| Net (decrease) increase in cash, cash equivalents and restricted cash | (71,530) | 19,970 | (70,996) |
| Cash, cash equivalents and restricted cash at beginning of period | 210,184 | 190,214 | 261,210 |
| Cash, cash equivalents and restricted cash at end of period | $138,654 | $210,184 | $190,214 |
| Supplemental disclosure of cash flow data: | |||
| Cash paid on interest | $9 | $— | $41 |
| Cash paid on income taxes | $3,176 | $2,716 | $1,046 |
Supplemental reconciliation of cash, cash equivalents and restricted cash reported within the consolidated balance sheets:
| Fiscal year ended January 31, | |||
|---|---|---|---|
| (in thousands) | 2025 | 2024 | 2023 |
| Cash and cash equivalents | $123,133 | $210,184 | $190,214 |
| Restricted cash, current and non-current | 15,521 | — | — |
| Total cash, cash equivalents and restricted cash | $138,654 | $210,184 | $190,214 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.